Search

everythinglearnresearchcommunity

for

Search:↓

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Hepatitis B vaccination can trigger HSP, and vitamin D correction and tonsillectomy can effectively manage it.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Cetuximab can cause skin cysts after acne-like eruptions.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

High-concentration cell-free adipose extract reduces scar formation and improves scar appearance.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Ebastine may help regrow hair in alopecia areata patients.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Cyproterone acetate effectively treats hirsutism and related conditions.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.